eris lifesciences

New Delhi: Even as the broader market is in a consolidation phase, dozens of stocks are sending 'sell' signals on MACD or moving average convergence divergence, as of Friday's close. In…

By Shardul Nautiyal Branded formulations manufacturer Eris Lifesciences now aims to post a 20 per cent to 25 per cent growth per annum in dermatology. This follows its recent acquisition…

Unless you have deep pockets and an extraordinary professional talent, it is very difficult to invest in new age companies for the next three to 10 years. So one should maximum invest with a…